Cargando…
LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer
Autores principales: | Xu, Yaqian, Yuan, Chenwei, Peng, Jing, Zhou, Liheng, Lin, Yanping, Wang, Yaohui, Zhang, Jie, Ma, Jiayi, Yin, Wenjin, Lu, Jinsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170602/ https://www.ncbi.nlm.nih.gov/pubmed/35685468 http://dx.doi.org/10.1016/j.gendis.2021.10.001 |
Ejemplares similares
-
LncRNA MIR31HG controls the proliferation and metastasis of gastric cancer by c-CBL-mediated degradation of β-catenin
por: Peng, Wen, et al.
Publicado: (2023) -
Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer
por: Bayarmaa, Battseren, et al.
Publicado: (2019) -
Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy
por: Xu, Yaqian, et al.
Publicado: (2020) -
Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy
por: Sha, Rui, et al.
Publicado: (2021) -
LncRNA MIR205HG regulates melanomagenesis via the miR-299-3p/VEGFA axis
por: Guo, Jinlan, et al.
Publicado: (2021)